Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (39)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Kreuzer, M.
Right arrow Articles by Wichmann, H-E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kreuzer, M.
Right arrow Articles by Wichmann, H-E.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

International Journal of Epidemiology 2003;32:263-271
© International Epidemiological Association 2003


Special Theme: Cancer

Hormonal factors and risk of lung cancer among women?

Michaela Kreuzer1, Michael Gerken2, Joachim Heinrich3, Lothar Kreienbrock4 and H-Erich Wichmann3

1 Institute of Radiation Hygiene, BfS—Federal Office for Radiation Protection, Neuherberg, Germany.
2 Tumour Centre, University of Regensburg, Regensburg, Germany.
3 Institute of Epidemiology, GSF—National Research Center for Environment and Health, Neuherberg, Germany.
4 Institute of Biometry, Epidemiology and Data Information Processing, School of Veterinary Medicine, University of Hannover, Hannover.

Correspondence: Dr Michaela Kreuzer, BfS-Institute of Radiation Hygiene, Ingolstädter Landstr. 1, 85764 Neuherberg, Germany. E-mail: mkreuzer{at}bfs.de

Background Gender differences in the histological distribution of lung carcinoma and a possibly greater susceptibility of women than men to tobacco carcinogens, suggest a possible influence of sex-specific hormones. This study examines endocrine factors and risk of lung cancer among women by smoking status and histology.

Methods We used data of a case-control study on lung cancer conducted from 1990 to 1996 in Germany, including 811 histologically confirmed female cases and 912 female population controls. Information on various menstrual and reproductive factors, use of oral contraceptives (OC), hormone replacement therapy (HRT), and smoking was gathered through personal interviews using a structured questionnaire. Odds ratios (OR) and 95% CI adjusted for age, region, smoking, and education were calculated via logistic regression.

Results A reduction in lung cancer risk was observed with the use of OC (OR = 0.69; 95% CI: 0.51–0.92), but no trend in risk with increasing duration of use, age at first use, or calendar year of first use was present. A history of HRT was associated with a reduced risk (OR = 0.83; 95% CI: 0.64–1.09), particularly after long duration (>=7 years) (OR = 0.59; 95% CI: 0.37–0.93). No clear association was found with regard to age at menarche, length of menstrual cycle, number of live-births, and age at menopause. Overall results did not differ much by histological cell subtype. The reduction in lung cancer risk associated with the use of exogenous hormones was primarily seen among smoking women.

Conclusions Our data provide evidence for a possible role of hormonal factors in the aetiology of lung cancer in women.


Keywords Case-control study, hormones, lung cancer, smoking, women

Accepted 14 December 2002


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Am J EpidemiolHome page
J. K. Paulus, K. Asomaning, P. Kraft, B. E. Johnson, X. Lin, and D. C. Christiani
Parity and Risk of Lung Cancer in Women
Am. J. Epidemiol., January 31, 2010; (2010): kwp441v1 - kwp441.
[Abstract] [Full Text] [PDF]


Home page
Anticancer ResHome page
J.-C. LAI, J.-Y. WU, Y.-W. CHENG, K.-T. YEH, T.-C. WU, C.-Y. CHEN, and H. LEE
O6-Methylguanine-DNA Methyltransferase Hypermethylation Modulated by 17{beta}-Estradiol in Lung Cancer Cells
Anticancer Res, July 1, 2009; 29(7): 2535 - 2540.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
M. L. Cote, W. Yoo, A. S. Wenzlaff, G. M. Prysak, S. K. Santer, G. B. Claeys, A. L. Van Dyke, S. J. Land, and A. G. Schwartz
Tobacco and estrogen metabolic polymorphisms and risk of non-small cell lung cancer in women
Carcinogenesis, April 1, 2009; 30(4): 626 - 635.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
A. Seow, W.-P. Koh, R. Wang, H.-P. Lee, and M. C. Yu
Reproductive Variables, Soy Intake, and Lung Cancer Risk among Nonsmoking Women in the Singapore Chinese Health Study
Cancer Epidemiol. Biomarkers Prev., March 1, 2009; 18(3): 821 - 827.
[Abstract] [Full Text] [PDF]


Home page
Am J EpidemiolHome page
J. M. Weiss, J. V. Lacey Jr., X.-O. Shu, B.-T. Ji, L. Hou, G. Yang, H. Li, N. Rothman, A. Blair, Y.-T. Gao, et al.
Menstrual and Reproductive Factors in Association With Lung Cancer in Female Lifetime Nonsmokers
Am. J. Epidemiol., December 1, 2008; 168(11): 1319 - 1325.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
D. Gallo, G. F. Zannoni, I. De Stefano, M. Mosca, C. Ferlini, E. Mantuano, and G. Scambia
Soy Phytochemicals Decrease Nonsmall Cell Lung Cancer Growth In Female Athymic Mice
J. Nutr., July 1, 2008; 138(7): 1360 - 1364.
[Abstract] [Full Text] [PDF]


Home page
Endocr Relat CancerHome page
Z. Hammoud, B. Tan, S. Badve, and R. M Bigsby
Estrogen promotes tumor progression in a genetically defined mouse model of lung adenocarcinoma
Endocr. Relat. Cancer, June 1, 2008; 15(2): 475 - 483.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
C. Rodriguez, H. Spencer Feigelson, A. Deka, A. V. Patel, E. J. Jacobs, M. J. Thun, and E. E. Calle
Postmenopausal Hormone Therapy and Lung Cancer Risk in the Cancer Prevention Study II Nutrition Cohort
Cancer Epidemiol. Biomarkers Prev., March 1, 2008; 17(3): 655 - 660.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
A. G. Schwartz, A. S. Wenzlaff, G. M. Prysak, V. Murphy, M. L. Cote, S. C. Brooks, D. F. Skafar, and F. Lonardo
Reproductive Factors, Hormone Use, Estrogen Receptor Expression and Risk of Non Small-Cell Lung Cancer in Women
J. Clin. Oncol., December 20, 2007; 25(36): 5785 - 5792.
[Abstract] [Full Text] [PDF]


Home page
Am J EpidemiolHome page
M. Hinkula, A. Kauppila, S. Nayha, and E. Pukkala
Cause-specific Mortality of Grand Multiparous Women in Finland
Am. J. Epidemiol., February 15, 2006; 163(4): 367 - 373.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
A. K. Ganti, A. E. Sahmoun, A. W. Panwalkar, K. K. Tendulkar, and A. Potti
Hormone Replacement Therapy Is Associated With Decreased Survival in Women With Lung Cancer
J. Clin. Oncol., January 1, 2006; 24(1): 59 - 63.
[Abstract] [Full Text] [PDF]


Home page
JAMAHome page
M. B. Schabath, L. M. Hernandez, X. Wu, P. C. Pillow, and M. R. Spitz
Dietary Phytoestrogens and Lung Cancer Risk
JAMA, September 28, 2005; 294(12): 1493 - 1504.
[Abstract] [Full Text] [PDF]


Home page
Eur. J. Cardiothorac. Surg.Home page
A. Iwasaki, T. Shirakusa, T. Shiraishi, and S. Yamamoto
Results of video-assisted thoracic surgery for stage I/II non-small cell lung cancer
Eur. J. Cardiothorac. Surg., July 1, 2004; 26(1): 158 - 164.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
M. B. Schabath, X. Wu, R. Vassilopoulou-Sellin, A. A. Vaporciyan, and M. R. Spitz
Hormone Replacement Therapy and Lung Cancer Risk: A Case-Control Analysis
Clin. Cancer Res., January 1, 2004; 10(1): 113 - 123.
[Abstract] [Full Text] [PDF]


Home page
Int J EpidemiolHome page
T. Lam and G. Leung
Geoethnic-sensitive and cross-culture collaborative epidemiological studies
Int. J. Epidemiol., April 1, 2003; 32(2): 178 - 180.
[Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.